Trial Profile
Post-marketing surveillance (PMS) study for efficacy and safety of pirfenidone in patients with idiopathic pulmonary fibrosis (IPF)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Nov 2015
Price :
$35
*
At a glance
- Drugs Pirfenidone (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Adverse reactions; Therapeutic Use
- 12 Aug 2014 New trial record